The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kennedy Giulia C since 2019.
This trader's CIK number is 1769333.
At the time of last reporting, Kennedy Giulia C was the Chief Scientific & Med Officer of Veracyte, Inc.. (stock ticker symbol VCYT).
Also see all insider trading activities at Veracyte, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | VCYT | 0 | $0 | 25,049 | $644,403 | 4,407 | $26,353 |
| 2021 | VCYT | 0 | $0 | 94,285 | $4,425,851 | 70,313 | $1,155,092 |
| 2020 | VCYT | 0 | $0 | 103,947 | $3,430,591 | 84,457 | $996,458 |
| 2019 | VCYT | 0 | $0 | 155,051 | $3,842,693 | 154,165 | $1,395,742 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-12-06 | VCYT | Sale | 1,023 | 27.03 | 27,651 |
| 2022-11-04 | VCYT | Sale | 1,023 | 25.00 | 25,575 |
| 2022-03-04 | VCYT | Option Ex | 4,407 | 5.98 | 26,353 |
| 2022-03-04 | VCYT | Sale | 23,003 | 25.70 | 591,177 |
| 2021-12-07 | VCYT | Sale | 6,125 | 40.62 | 248,797 |
| 2021-12-06 | VCYT | Sale | 9,232 | 36.25 | 334,623 |
| 2021-12-07 | VCYT | Option Ex | 6,125 | 25.62 | 156,922 |
| 2021-12-06 | VCYT | Option Ex | 8,156 | 13.10 | 106,802 |
| 2021-09-07 | VCYT | Option Ex | 12,531 | 16.96 | 212,525 |
| 2021-09-07 | VCYT | Sale | 12,531 | 50.88 | 637,527 |
| 2021-09-08 | VCYT | Sale | 926 | 50.53 | 46,790 |
| 2021-06-23 | VCYT | Sale | 4,375 | 39.75 | 173,915 |
| 2021-06-23 | VCYT | Option Ex | 4,375 | 24.69 | 108,018 |
| 2021-06-04 | VCYT | Option Ex | 8,156 | 13.10 | 106,802 |
| 2021-06-04 | VCYT | Sale | 9,081 | 34.28 | 311,305 |
| 2021-03-04 | VCYT | Option Ex | 30,970 | 14.98 | 464,023 |
| 2021-03-04 | VCYT | Sale | 52,015 | 51.39 | 2,672,894 |
| 2020-12-04 | VCYT | Option Ex | 13,468 | 11.75 | 158,208 |
| 2020-12-04 | VCYT | Sale | 14,015 | 56.73 | 795,056 |
| 2020-10-06 | VCYT | Option Ex | 2,500 | 20.21 | 50,525 |
| 2020-10-06 | VCYT | Sale | 2,500 | 35.21 | 88,025 |
| 2020-09-04 | VCYT | Option Ex | 6,479 | 7.51 | 48,689 |
| 2020-09-04 | VCYT | Sale | 7,027 | 31.16 | 218,996 |
| 2020-07-31 | VCYT | Sale | 20,000 | 35.34 | 706,700 |
| 2020-07-31 | VCYT | Option Ex | 20,000 | 20.21 | 404,200 |
| 2020-07-13 | VCYT | Option Ex | 16,738 | 9.79 | 163,865 |
| 2020-07-13 | VCYT | Sale | 16,738 | 29.66 | 496,365 |
| 2020-06-03 | VCYT | Option Ex | 10,239 | 6.82 | 69,829 |
| 2020-06-03 | VCYT | Sale | 10,786 | 26.22 | 282,808 |
| 2020-03-03 | VCYT | Option Ex | 15,033 | 6.73 | 101,142 |
| 2020-03-03 | VCYT | Sale | 32,881 | 25.63 | 842,641 |
| 2019-12-05 | VCYT | Option Ex | 32,803 | 14.34 | 470,395 |
| 2019-12-05 | VCYT | Sale | 32,803 | 29.39 | 964,145 |
| 2019-12-03 | VCYT | Option Ex | 15,032 | 6.73 | 101,135 |
| 2019-12-03 | VCYT | Sale | 15,327 | 26.47 | 405,659 |
| 2019-11-27 | VCYT | Sale | 3,697 | 29.36 | 108,532 |
| 2019-11-27 | VCYT | Option Ex | 3,697 | 14.34 | 53,014 |
| 2019-09-04 | VCYT | Sale | 296 | 25.20 | 7,458 |
| 2019-09-03 | VCYT | Option Ex | 15,031 | 6.73 | 101,128 |
| 2019-09-03 | VCYT | Sale | 15,031 | 25.66 | 385,725 |
| 2019-08-13 | VCYT | Sale | 4,640 | 25.45 | 118,088 |
| 2019-08-12 | VCYT | Sale | 28,257 | 25.38 | 717,106 |
| 2019-08-13 | VCYT | Option Ex | 4,640 | 10.45 | 48,488 |
| 2019-08-12 | VCYT | Option Ex | 27,962 | 7.70 | 215,391 |
| 2019-03-04 | VCYT | Option Ex | 17,625 | 5.98 | 105,397 |
| 2019-03-04 | VCYT | Sale | 17,625 | 20.24 | 356,712 |
| 2019-02-28 | VCYT | Sale | 37,375 | 20.85 | 779,268 |
| 2019-02-28 | VCYT | Option Ex | 37,375 | 8.05 | 300,794 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kennedy Giulia C (Chief Scientific & Med Officer of Veracyte, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.